Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate.

Auteur(s) : Anna Lopez-Ferrer1, Luis Puig1, Gerardo Moreno2, Alejandro Camps-Fresneda2, Jose Palou3, Agustin Alomar1 1Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain 2Dermalas, Clinica Teknon, Barcelona, Spain 3Unitat de Dermatopatologia, Barcelona, Spain Infliximab, a chimeric monoclonal antibody that binds to free and membrane-bound tumor necrosis factor (TNF)-α, has been demonstrated to be effective in treating immune-mediated inflammatory [...]